Your browser doesn't support javascript.
loading
Serotype IV Streptococcus agalactiae ST-452 has arisen from large genomic recombination events between CC23 and the hypervirulent CC17 lineages.
Campisi, Edmondo; Rinaudo, C Daniela; Donati, Claudio; Barucco, Mara; Torricelli, Giulia; Edwards, Morven S; Baker, Carol J; Margarit, Imma; Rosini, Roberto.
Affiliation
  • Campisi E; GSK Vaccines s.r.l., Siena, Italy.
  • Rinaudo CD; Sapienza, Università di Roma, Rome, Italy.
  • Donati C; GSK Vaccines s.r.l., Siena, Italy.
  • Barucco M; Department of Computational Biology, Research and Innovation Centre, Fondazione Edmund Mach, San Michele all'Adige, Italy.
  • Torricelli G; GSK Vaccines s.r.l., Siena, Italy.
  • Edwards MS; Department of physics "Enrico Fermi", University of Pisa, Pisa, Italy.
  • Baker CJ; GSK Vaccines s.r.l., Siena, Italy.
  • Margarit I; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
  • Rosini R; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
Sci Rep ; 6: 29799, 2016 07 14.
Article in En | MEDLINE | ID: mdl-27411639

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Streptococcus agalactiae / Genome, Bacterial / Genomics / Whole Genome Sequencing Limits: Adult / Humans / Newborn Language: En Journal: Sci Rep Year: 2016 Document type: Article Affiliation country: Italia Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Streptococcus agalactiae / Genome, Bacterial / Genomics / Whole Genome Sequencing Limits: Adult / Humans / Newborn Language: En Journal: Sci Rep Year: 2016 Document type: Article Affiliation country: Italia Country of publication: Reino Unido